SCHEMBL23901671

SCHEMBL23901671

CC(C)N1CCN([C@H](c2ccccc2)[C@@H](O)c2ccccc2)CC1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.51
CYP2D6 P10635 6/20 0.50
CYP3A4 P08684 5/20 0.50
CYP2C19 P33261 5/20 0.50
CYP1A2 P05177 4/20 0.50
CYP2C9 P11712 4/20 0.50
KCNA5 P22460 4/20 0.50
KCNH2 Q12809 4/20 0.50
KCNE1 P15382 1/20 0.48
ALDH1A1 P00352 3/20 0.47
TSHR P16473 1/20 0.47
CHRM1 P11229 1/20 0.47
KDM4E B2RXH2 2/20 0.46
ADRA2A P08913 1/20 0.46
ADRA2C P18825 1/20 0.46
LMNA P02545 1/20 0.46
HIF1A Q16665 1/20 0.46
MC4R P32245 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23901673 0.86 CYP2D6 (0.59) MAOBCYP2D6CYP3A4CYP2C19CYP1A2
Hydrochloric Acid SCHEMBL11817710 0.84 KCNH2 (0.58) MAOBCYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL18704989 0.84 GRIN2B (0.52) CYP2D6CYP3A4CYP1A2KCNH2TSHR
SCHEMBL23496077 0.83 CYP2C19 (0.73) MAOBCYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL7089852 0.83 CYP2C19 (0.73) MAOBCYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL4873121 0.83 CYP2C19 (0.73) MAOBCYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL25453185 0.81 CYP2D6 (0.53) MAOBCYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL9366911 0.81 KCNA5 (0.74) MAOBCYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL4875640 0.81 KCNA5 (0.74) MAOBCYP2D6CYP3A4CYP2C19CYP1A2
SCHEMBL4874914 0.79 CYP3A4 (0.61) MAOBCYP2D6CYP3A4CYP2C19CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230143470-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ NATIONAL INSTITUTES OF HEALTH 2023-05-11 US disclosed
WO-2021202600-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ THE SCRIPPS RESEARCH INSTITUTE (US) 2021-10-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230143470-A1 SMALL MOLECULE INHIBITORS OF INFLUENZA HEMAGGLUTININ HAVCR2, CD44, ENGASE MAOB 688/4885CYP2D6 4663/4885CYP3A4 4671/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.